Detalles de la búsqueda
1.
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
BMC Cancer
; 14: 277, 2014 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24755296
2.
VEGF expression in the colorectal adenoma-carcinoma sequence.
Oncol Res
; 15(9): 445-51, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16555551
3.
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
Int J Radiat Oncol Biol Phys
; 52(1): 144-55, 2002 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11777632
4.
A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
Anticancer Res
; 22(6B): 3743-8, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12552987
5.
Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
J Thorac Oncol
; 3(5): 505-10, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18449003
6.
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
Int J Cancer
; 108(4): 620-7, 2004 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-14696130
Resultados
1 -
6
de 6
1
Próxima >
>>